Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-v5vhk Total loading time: 0 Render date: 2024-06-21T09:44:05.285Z Has data issue: false hasContentIssue false

16 - Can We Make Opioid Misuse Less Dangerous?

from Part IV - Recovery

Published online by Cambridge University Press:  07 October 2023

Ethan O. Bryson
Affiliation:
Icahn School of Medicine at Mount Sinai, New York
Christine E. Boxhorn
Affiliation:
Medical College of Wisconsin, Milwaukee
Get access

Summary

Chronic opioid misuse puts people at significant risk for developing multiple health problems, caused either by decreased access to preventative care, exposure to blood-borne or sexually transmitted diseases or as a direct result of chronically elevated levels of exogenous opioids. People with opioid use disorder often suffer from chronic pain and mental illness at rates much higher than in the general population and are at significant risk for financial ruin, homelessness, overdose, and death. While it may not be possible to make opioid use completely safe, if we can, we should make it less dangerous. Illicit opioids are often impure and adulterated after production. They must be procured illegally and are often injected with unsterile equipment in an unsafe and unsupervised environment. All of these factors can and should be addressed as part of a comprehensive strategy to fight the opioid epidemic. Only by challenging the beliefs that underlie the stigma surrounding opioid use disorder and directly addressing the factors that contribute to the increased morbidity and mortality associated with chronic opioid misuse can we turn the tide of the epidemic.

Type
Chapter
Information
The Opioid Epidemic
Origins, Current State and Potential Solutions
, pp. 204 - 217
Publisher: Cambridge University Press
Print publication year: 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References and Further Reading

Baltimore Sun (2017). Is Md. ready for ‘heroin assisted therapy’? Baltimore Sun, April 10.Google Scholar
Barnett, PG, Sorensen, JL, Wong, W, Haug, NA, Hall, SM (2009). Effect of incentives for medication adherence on health care use and costs in methadone patients with HIV. Drug Alcohol Depend 100(1–2):115121.Google Scholar
Guardian (2022). Canada to decriminalize some drugs in British Columbia for three years. Guardian, May 31. www.theguardian.com/world/2022/may/31/canada-decriminalize-drugs-british-columbia-overdoses.Google Scholar
Hiragaki, S, Suzuki, T, Mohamed, AAM, Takeda, M. (2015). Structures and functions of insect arylalkylamine Nacetyltransferase (iaaNAT): A key enzyme for physiological and behavioral switch in arthropods. Frontiers in Physiology 6: 113.Google Scholar
Laqueur, H (2015). Uses and abuses of drug decriminalization in Portugal. Law & Social Inquiry 40(3): 746781.Google Scholar
Morris, J and Gillies, R (2022). Drug criminalization test OKed. San Francisco Chronicle, June 2, p. A2.Google Scholar
NIDA (2014). Principles of drug addiction treatment: A research-based guide (third edition). https://archives.nida.nih.gov/publications/principles-drug-addiction-treatment-research-based-guide-third-edition.Google Scholar
Oregon State Government (2020). Drug Addiction Treatment and Recovery Act (Measure 110). www.oregon.gov/oha/hsd/amh/pages/measure110.aspx.Google Scholar
Oviedo-Joekes, E, Brissette, S, Marsh, DC, et al. (2009). Diacetylmorphine versus methadone for the treatment of opioid addiction. New England Journal of Medicine 361(8): 777786.Google Scholar
Sordo, L, Barrio, G, Bravo, MJ, et al. (2017). Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.British Medical Journal 357: j1550.Google Scholar
Strang, J, Teodora Groshkova, T, Metrebian, N. (2012). EMCDDA Insights. New Heroin-Assisted Treatment: Recent Evidence and Current Practices of Supervised Injectable Heroin Treatment in Europe and Beyond. Lisbon: European Monitoring Center for Drugs and Addiction.Google Scholar
Strang, J, Groshkova, T, Uchtenhagen, A, et al. (2015). Heroin on trial: Systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction. British Journal of Psychiatry 207(1): 514.Google Scholar
van Staaden, MJ, Hall, FS, Huber, R. T (2018). The deep evolutionary roots of ‘addiction’. Journal of Mental Health and Clinical Psychology 2(3): 813.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×